top of page

Sutinat 12.5 mg Capsule

SKU Natco Pharma Ltd
Precio original

56,66$

Precio de oferta

46,46$

Sutinat 12.5 mg capsules are a targeted anticancer treatment designed to combat various malignancies, including pancreatic cancer, gastrointestinal stromal tumors, and renal cell carcinoma. This innovative medication operates by inhibiting the growth and spread of cancerous cells, effectively disrupting their ability to proliferate. Patients using Sutinat should be aware of potential side effects, which may include fatigue, nausea, and changes in appetite, necessitating regular monitoring by healthcare professionals. It is crucial to discuss any pre-existing conditions or ongoing medications with your doctor before starting Sutinat to minimize the risk of adverse reactions. This medication is taken orally, usually once a day, and should be administered consistently for optimal results. With its precise action against tumor growth, Sutinat 12.5 mg serves as a vital option for those battling challenging cancer types. Always consult your healthcare provider for personalized guidance and to ensure the best therapeutic outcomes while using this medication.

Cantidad

Active Pharmaceutical Ingredient

Sunitinib 12.5 mg

Uses

• Sutinat 1•5 mg capsule is utilized in the treatment of Advanced Renal Cell Carcinoma (RCC). This type of kidney cancer arises from the small tubes within the kidney. By targeting the cancer cells, Sutinat 1•5 mg capsule helps to slow disease progression and improve patient outcomes. It is commonly prescribed when the cancer is advanced and requires effective management.
• Another significant application of Sutinat 1•5 mg capsule is in the treatment of Gastrointestinal Stromal Tumors (GIST). GISTs are rare tumors that develop in the digestive tract, often affecting the stomach or small intestine. Sutinat 1•5 mg capsule works by inhibiting specific pathways that promote the growth of these tumors. This targeted approach is crucial for patients facing this uncommon cancer type.
• Sutinat 1•5 mg capsule is also indicated for the management of Pancreatic Neuroendocrine Tumors (PNETs). These tumors originate from the hormone-producing cells in the pancreas. By using Sutinat 1•5 mg capsule, healthcare providers aim to control tumor growth and enhance the quality of life for patients. This treatment option is particularly important due to the rarity and complexity of PNETs.

Benefits

Sunitinib Capsule 12.5 mg is used to treat specific forms of cancer, such as gastrointestinal stromal tumors (GISTs), renal cell carcinoma (RCC), and imatinib-resistant GIST. The advantages of using Anti-cancer Drug Sutinat may involve reducing the size of cancerous tumors, slowing the progression and spread of cancer, alleviating cancer-related symptoms, and potentially extending survival in some individuals.

Side Effects

Like all medicines, Sutinat 12.5 mg Capsule may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.

Most Common Side Effects

• Complete or Partial hair loss
• Change in hair and skin colour
• Back pain
• Stomach upset
• Dry skin
• Diarrhea
• Swollen eyes
• Tingling sensation in limbs
• Nausea and Vomiting
• Tiredness
• Muscle spasms

Common Side Effects

• Headache
• Blistered palm
• Rashes
• Sores mouth or tongue
• Bleeding
• Swollen and Painful limbs
• decreased vision
• Blood in stool
• Fast heartbeat
• Sweating
• Hypertension
• Panful urination
• Unusual weight gain
• Trouble breathing
• serious side effects
• Dizziness
• Fatal skin reaction

How To Use

You may take this medicine with or without a meal. It is recommended that you swallow the tablet whole with a full glass of water and that you do not crush, chew, or break the tablet. If you miss a dose of this medicine, take it as soon as you can. Skip the missed dose and return to your regular dosing schedule if it is almost time for your next dose. Do not take a double dose of your medicine to make up for a missed dose.

Safety Advice

• Alcohol: Drinking alcohol while taking Sutinat Capsule is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Sunitinib Capsule 12.5 mg in patients with kidney disease. No dose adjustment of Sutinat 12.5 mg Capsule is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Sutinat Capsule. Sutinat 12.5 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Anti-cancer Drug Sutinat, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Sunitinib Capsule 12.5 mg is safe for use in patients with mild to moderate liver disease, no dose adjustment of Sutinat 12.5 mg Capsule is recommended. The use of Anti-cancer Drug Sutinat is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Sutinat 12.5 mg Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Sunitinib Capsule 12.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Sutinat 12.5 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Anti-cancer Drug Sutinat.

bottom of page